Back to top

TD Cowen Remains a Hold on Spero Therapeutics (SPRO)

TD Cowen analyst Ritu Baral maintained a Hold rating on Spero Therapeutics (SPRO – Research Report) today. The company’s shares closed today at $2....

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Spero Therapeutics, Inc. (SPRO)